320 related articles for article (PubMed ID: 26778668)
1. Targeting MYC in cancer therapy: RNA processing offers new opportunities.
Koh CM; Sabò A; Guccione E
Bioessays; 2016 Mar; 38(3):266-75. PubMed ID: 26778668
[TBL] [Abstract][Full Text] [Related]
2. Mission Possible: Advances in MYC Therapeutic Targeting in Cancer.
Allen-Petersen BL; Sears RC
BioDrugs; 2019 Oct; 33(5):539-553. PubMed ID: 31392631
[TBL] [Abstract][Full Text] [Related]
3. The Myc oncoprotein as a therapeutic target for human cancer.
Vita M; Henriksson M
Semin Cancer Biol; 2006 Aug; 16(4):318-30. PubMed ID: 16934487
[TBL] [Abstract][Full Text] [Related]
4. The Molecular 'Myc-anisms' Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics.
McAnulty J; DiFeo A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322239
[No Abstract] [Full Text] [Related]
5. MYC-mediated synthetic lethality for treating tumors.
Li X; Zhang XA; Li X; Xie W; Huang S
Curr Cancer Drug Targets; 2015; 15(2):99-115. PubMed ID: 25553514
[TBL] [Abstract][Full Text] [Related]
6. Myc and mRNA capping.
Dunn S; Cowling VH
Biochim Biophys Acta; 2015 May; 1849(5):501-5. PubMed ID: 24681440
[TBL] [Abstract][Full Text] [Related]
7. c-Myc deregulation induces mRNA capping enzyme dependency.
Lombardi O; Varshney D; Phillips NM; Cowling VH
Oncotarget; 2016 Dec; 7(50):82273-82288. PubMed ID: 27756891
[TBL] [Abstract][Full Text] [Related]
8. Targeting RNA polymerase I to treat MYC-driven cancer.
Poortinga G; Quinn LM; Hannan RD
Oncogene; 2015 Jan; 34(4):403-12. PubMed ID: 24608428
[TBL] [Abstract][Full Text] [Related]
9. The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth.
Pelengaris S; Khan M
Expert Opin Ther Targets; 2003 Oct; 7(5):623-42. PubMed ID: 14498825
[TBL] [Abstract][Full Text] [Related]
10. c-Myc suppressed E-cadherin through miR-9 at the post-transcriptional level.
Liu M; Zhu H; Yang S; Wang Z; Bai J; Xu N
Cell Biol Int; 2013 Mar; 37(3):197-202. PubMed ID: 23364919
[TBL] [Abstract][Full Text] [Related]
11. Cancer therapeutics: targeting the dark side of Myc.
Ponzielli R; Katz S; Barsyte-Lovejoy D; Penn LZ
Eur J Cancer; 2005 Nov; 41(16):2485-501. PubMed ID: 16243519
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathways: Targeting MYC-induced metabolic reprogramming and oncogenic stress in cancer.
Li B; Simon MC
Clin Cancer Res; 2013 Nov; 19(21):5835-41. PubMed ID: 23897900
[TBL] [Abstract][Full Text] [Related]
13. MYC as a target for cancer treatment.
Duffy MJ; O'Grady S; Tang M; Crown J
Cancer Treat Rev; 2021 Mar; 94():102154. PubMed ID: 33524794
[TBL] [Abstract][Full Text] [Related]
14. RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma.
Lee HC; Wang H; Baladandayuthapani V; Lin H; He J; Jones RJ; Kuiatse I; Gu D; Wang Z; Ma W; Lim J; O'Brien S; Keats J; Yang J; Davis RE; Orlowski RZ
Br J Haematol; 2017 Apr; 177(1):80-94. PubMed ID: 28369725
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.
Wang B; Hsu SH; Wang X; Kutay H; Bid HK; Yu J; Ganju RK; Jacob ST; Yuneva M; Ghoshal K
Hepatology; 2014 Feb; 59(2):555-66. PubMed ID: 24038073
[TBL] [Abstract][Full Text] [Related]
16. Taking on challenging targets: making MYC druggable.
Horiuchi D; Anderton B; Goga A
Am Soc Clin Oncol Educ Book; 2014; ():e497-502. PubMed ID: 24857145
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway.
Rahmutulla B; Matsushita K; Satoh M; Seimiya M; Tsuchida S; Kubo S; Shimada H; Ohtsuka M; Miyazaki M; Nomura F
Oncotarget; 2014 May; 5(9):2404-17. PubMed ID: 24811221
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of common genes by c-Myc and its direct target, MT-MC1.
Rogulski KR; Cohen DE; Corcoran DL; Benos PV; Prochownik EV
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):18968-73. PubMed ID: 16365299
[TBL] [Abstract][Full Text] [Related]
19. Function of the c-Myc oncoprotein.
Kato GJ; Dang CV
FASEB J; 1992 Sep; 6(12):3065-72. PubMed ID: 1521738
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers.
Schick M; Habringer S; Nilsson JA; Keller U
Br J Haematol; 2017 Dec; 179(5):724-738. PubMed ID: 29171017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
